
Fineotex Chemical Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Tue Apr 14 2026

Fineotex Chemical (NSE: FINEOTEX) is scheduled to declare its Q4 FY26 results on May 12, 2026, when the board of directors will approve the audited financial statements for the January–March 2026 quarter and the full year FY2025–26. The stock trades at Rs 285 as of April 2026 — down -37% from its 52-week high of Rs 460 — making this a closely watched quarter for investors assessing whether the correction represents opportunity or ongoing fundamental pressure.
This Q4 FY26 results preview for Fineotex Chemical covers the confirmed results date, analyst consensus estimates, five key performance factors, five risks to monitor, analyst ratings, and the complete share price outlook. Q4 FY26 is particularly significant as it delivers the full-year FY26 results alongside the first management commentary on FY27 business outlook.
Get free investment predictions from SEBI-registered analysts on Univest.
Fineotex Chemical Q4 Results 2026 Date
The Fineotex Chemical Q4 FY26 results date is May 12, 2026. The board of directors meeting will approve the quarter and full-year FY26 financial results, consider a final dividend recommendation for FY26, and provide management guidance for FY27.
| Company | Q4 Results Date | Key Metric to Watch |
| [object Object] | April 9, 2026 (Declared) | FY27 CC guidance + deal TCV |
| [object Object] | April 23, 2026 | CC revenue growth guidance |
| Bharti Airtel | April 29, 2026 | ARPU + 5G subscribers |
| Dr. Lal Path Labs | May 8, 2026 | Test volume + EBITDA margin |
| Fineotex Chemical | May 12, 2026 | See estimates below |
Why Q4 FY26 Matters
Q4 (January–March 2026) is the final quarter of FY2025–26 and carries the highest informational weight of any quarterly result. Beyond the Q4 standalone performance, investors receive: the complete FY26 annual revenue, PAT, and margin profile; management’s first formal FY27 revenue and margin guidance; the final dividend recommendation; and qualitative commentary on demand environment and competitive dynamics entering the new fiscal year.
For Fineotex Chemical specifically, Q4 captures the peak-season dynamics of the Specialty Textile Chemicals sector — a quarter where operating leverage typically manifests most visibly if demand conditions are favourable.
Fineotex Chemical Q4 FY26 Earnings Estimates

Access premium analyst research on Univest.
Based on publicly available analyst consensus data, the following are the Q4 FY26 estimates for Fineotex Chemical:
| Metric | Q4 FY26 Estimate | Q3 FY26 Actual | QoQ Trend |
| Revenue | Rs 185 Cr | Rs 165 Cr | Sequential improvement expected |
| Net Profit (PAT) | Rs 22 Cr | Rs 19 Cr | Normalisation in progress |
| Margin | EBITDA 18% | Q3 FY26 level | Stable to improving |
| Volume / Growth Driver | +12% volume YoY | Prior quarter | YoY comparison |
| Final Dividend (Expected) | Rs 2 | FY26 interim dividends | Board decision |
Screen Fineotex Chemical live on the Univest Screener — real-time fundamentals, FII/DII flows, and analyst ratings.
Download the Univest iOS App or Univest Android App for real-time Q4 result alerts.
5 Key Factors Driving Fineotex Chemical Q4 FY26 Performance
1. Revenue Growth Momentum
Fineotex Chemical’s core business is tracking the broader sector recovery in Q4 FY26. Seasonal demand patterns and year-end procurement cycles support revenue trajectory.
2. Operating Leverage
Revenue growth above fixed cost base growth translates to EBITDA margin improvement as the business scales.
3. Market Share Expansion
Any market share gain in the primary business segment would add incremental volume beyond sector growth rates.
4. Management FY27 Guidance
Q4 FY26 results will include the first formal FY27 outlook commentary — setting the investment narrative for the next 12 months.
5. Balance Sheet and Cash Flow
Q4 typically generates the strongest operating cash flow. Debt reduction or capex commitment will signal balance sheet direction.
5 Risks to Watch in Fineotex Chemical Q4 FY26
Risk 1: Input Cost Volatility
Raw material and input cost changes can compress margins unexpectedly within a quarter.
Risk 2: Revenue Concentration Risk
Customer or geographic concentration creates quarterly revenue variance risk.
Risk 3: Competitive Pressure
Market competition in the Specialty Textile Chemicals sector may intensify, requiring additional price or volume concessions.
Risk 4: Regulatory Environment
Policy and regulatory changes affecting the sector can create revenue or compliance cost risks.
Risk 5: Macroeconomic Sensitivity
Global and domestic macroeconomic conditions — tariffs, interest rates, consumption trends — affect end-market demand.
Fineotex Chemical Share Price and Analyst Ratings

| Parameter | Value |
| CMP (April 2026) | Rs 285 |
| 52-Week High | Rs 460 |
| 52-Week Low | Rs 250 |
| 1-Year Return | -37% |
| Market Capitalisation | Rs 1,200 Cr |
| Sector | Specialty Textile Chemicals |
| NSE Ticker | FINEOTEX |
| Q4 Results Date | May 12, 2026 |
| Brokerage | Rating | Thesis Summary |
| Motilal Oswal | BUY | Q4 recovery potential; sector tailwinds intact |
| YES Securities | ADD | Earnings inflection expected; watch Q4 guidance |
| Kotak Institutional | NEUTRAL | Fair valued at current levels; execution key |
Conclusion
Fineotex Chemical Q4 FY26 results on May 12, 2026 will be the most important quarterly event of FY26. At Rs 285 — down -37% from its 52-week high of Rs 460 — the stock enters results season having already priced in significant headwinds. Revenue above Rs 185 Cr with EBITDA 18% would constitute a beat relative to current analyst consensus. Management’s FY27 guidance on 12% volume YoY trajectory will be the primary re-rating catalyst.
Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information. Verify all numbers before investing. Consult a SEBI-registered financial advisor before making investment decisions.
For more Q4 FY26 results previews, visit Univest Blogs.
Frequently Asked Questions
Q: When is Fineotex Chemical Q4 results 2026 date?
Fineotex Chemical Q4 FY26 results date is May 12, 2026. The board will approve the quarter and full-year FY26 financial results, consider a final dividend, and provide FY27 guidance.
Q: What is Fineotex Chemical Q4 FY26 revenue estimate?
Analyst consensus estimate for Fineotex Chemical Q4 FY26 revenue is Rs 185 Cr. Q3 FY26 actual revenue was Rs 165 Cr. Actual Q4 results may differ based on operating conditions and management execution.
Q: What is Fineotex Chemical Q4 FY26 PAT estimate?
Analyst consensus estimate for Fineotex Chemical Q4 FY26 net profit (PAT) is Rs 22 Cr. Q3 FY26 actual PAT was Rs 19 Cr. Estimates are indicative and subject to quarterly variance.
Q: Will Fineotex Chemical declare a dividend in Q4 FY26?
Fineotex Chemical is expected to declare Rs 2 for FY26, subject to board approval at the May 12, 2026 meeting and subsequent shareholder approval at the AGM. Verify actual dividend announcement before making any investment decision.
Q: What is Fineotex Chemical current share price?
Fineotex Chemical is trading at Rs 285 as of April 2026 — down -37% from its 52-week high of Rs 460. The 52-week low is Rs 250. Track the live price on the Univest Screener.
Q: What were Fineotex Chemical Q3 FY26 results?
In Q3 FY26, Fineotex Chemical reported revenue of Rs 165 Cr and net profit (PAT) of Rs 19 Cr. Q4 FY26 results on May 12, 2026 will provide the full-year FY26 comparison.
Q: When do TCS and Infosys announce Q4 results 2026?
TCS declared Q4 FY26 results on April 9, 2026. Infosys is scheduled for April 23, 2026. Both are covered in detail at univest.in/blogs. Check the earnings calendar table above for other key result dates.
Q: Is Fineotex Chemical a good investment ahead of Q4 results?
This article does not constitute investment advice. Fineotex Chemical at Rs 285 trades -37% below its 52-week high of Rs 460. Analyst consensus estimates suggest Q4 FY26 revenue of Rs 185 Cr and PAT of Rs 22 Cr. Review the factors, risks, and analyst ratings above. Consult a SEBI-registered financial advisor before making any investment decision.
Recent Article
Balkrishna Industries Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Balkrishna Paper Mills Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
BALAXI PHARMACEUTICALS Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Balaji Telefilms Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Balaji Amines Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Related Posts
BLS International Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
BLS E-Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Hi-Tech Pipes Q4 Results 2026: Date, Revenue, PAT And Analyst Outlook
Bliss GVS Pharma Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
HFCL Q4 Results 2026: Date, Revenue, PAT And Analyst Outlook

